Gaxos.ai
Builds consumer AI applications and non-clinical telehealth administration services.
Something off on this page? Send us feedback.
Profile
Sells AI subscriptions, biomarker-based wellness coaching, and non-clinical telehealth administration services through Gaxos Labs, Gaxos Health, and RNK Health. Revenue centers on RNK's commission-based administrative work, while a small internal team relies on external specialists.
Develops consumer AI applications through Gaxos Labs, including UNGPT for text humanization and SEO writing, ART-GEN for image and video creation, and BIBLE PRAY for personalized devotionals, guided prayers, and Bible study. Gaxos Health offers biomarker- and goal-based wellness plans, covering fitness, nutrition, progress tracking, and live coaching.
Earns subscription revenue from software applications and commission revenue from RNK Health's non-clinical patient administration, including intake, scheduling, care navigation, education, pathway monitoring, and data collection. RNK's medical partner serves telehealth patients across the United States and provides licensed professionals, telehealth technology, medication management, and clinical support, while external specialists support development and operations. Operations depend on third-party technology providers and health, privacy, and cybersecurity requirements.
Company facts
Categories
Key statistics
Year to date −32.4% · Average volume (30d) 4.5M
Analysts
No analyst consensus on record.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026Q2 FY26 | −$0.15 | $0.02 | +113.3% | $1.8M | $2.5M | +36.7% | +44.74% |
| May 14, 2026Q1 FY26 | −$0.20 | −$0.25 | −25.0% | $1.8M | $1.8M | +0.5% | −1.64% |
| Mar 17, 2026Q4 FY25 | −$0.16 | −$0.13 | +18.8% | $996.5K | $1.2M | +20.4% | +13.24% |
| Nov 13, 2025Q3 FY25 | — | −$0.14 | — | — | $498.3K | — | −4.41% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $23.7K | $171.0K | $498.3K | $1.2M | $1.8M | $2.5M | |
| Gross profit | $23.7K | $114.4K | $498.3K | $1.2M | $1.8M | $2.4M | |
| Operating income | −$1.4M | −$982.7K | −$1.3M | −$1.2M | −$2.5M | −$1.9M | |
| Net income | −$1.2M | −$749.4K | −$1.0M | −$957.9K | −$2.2M | $241.1K | |
| Diluted EPS | −$0.17 | −$0.11 | −$0.14 | −$0.13 | −$0.25 | $0.02 | |
| Gross margin | 100.0% | 66.9% | 100.0% | 95.2% | 100.0% | 97.6% | |
| Operating margin | -5,864.2% | -574.8% | -263.9% | -99.0% | -140.8% | -75.9% |
Fiscal years (4-quarter sums)FY22 $0 · FY23 $256 · FY24 $4.0K · FY25 $1.9M
Revenue by product · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $11.5M · Total debt $0 · Total assets $17.5M · Shareholders' equity $17.3M
Dividends
No dividends on record.
Ownership
Shares outstanding 10.22M · Float 10.00M · 97.8% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 207.6K | 9.99% | 13D/G | Nov 14, 2024 |
| Geode Capital Management, LLC | 121.5K | 1.19% | 13F | May 15, 2026 |
| Vanguard Capital Management LLC | 64.6K | 0.63% | 13F | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 36.0K | 0.35% | 13F | May 8, 2026 |
| Jane Street Group, LLC | 30.2K | 0.30% | 13F | May 12, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
View detailsPeers
- Hims & Hers Health
Digital weight-loss care and medication access.
- GoodRx
Online care, prescription savings, and patient access.
- Adobe
Generative image and video creation subscriptions.
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Gaxos.ai | $0.7901 | +0.79% | $8.0M | — | — | 1.3 | +1,338.8% |
| Hims & Hers Health | $28.86 | +0.10% | $6.43B | — | 110.6 | 2.5 | +38.3% |
| GoodRx | $3.53 | −0.42% | $1.22B | 83.1 | 10.4 | 1.6 | −1.3% |
| Adobe | $291.46 | −0.04% | $115.88B | 16.7 | 11.3 | 4.6 | +12.7% |
| Median | 49.9 | 11.3 | 2.5 | +12.7% |